Senior insider sale
EVP & Co-Head Research & Inv. at ROYALTY PHARMA PLC — senior position signals high conviction
$1.45M
27.37K shares
What this filing means
URIST MARSHALL plans to sell 27.37K shares of ROYALTY PHARMA PLC valued at approximately $1.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/20/2026ACC: 0001964306-26-000251
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
27.37K
Shares to sell
$1.45M
Approx. market value
13.68K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Equity Performance Award
Granted as part of issuer equity compensation program
2/11/2026
13.68KTotal acquired13.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Equity Performance Award Granted as part of issuer equity compensation program | 13.68K | — |
| Total | 13.68K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
13.68K
Market value
$726.1K
5/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
13.68K
Market value
$721.8K
5/20/2026
Total
Units
27.37K
Value
$1.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/14/2026 | 13.68K | $726.1K | — | Completed |
| Planned — Approximate Date | ||||
5/20/2026 | 13.68K | $721.8K | NASDAQ | Planned |
| Total | 27.37K | $1.45M | ||